Amundi IS DJ Switzerland Titans 30 UCITS ETF Dist

This Sub-Fund is passively managed. The objective of this Sub-Fund is to track the performance of the Dow Jones Switzerland Titans 30 Total Return Index (the "Index"), and to minimize the tracking error between the net asset value of the Sub-Fund and the performance of the Index. The anticipated level of the tracking error, under normal market conditions, is indicated in the prospectus of the Sub-Fund. The Index is a Net Total Return Index: dividends net of tax paid by the Index constituents are included in the Index return. The Index is composed of the shares of the 30 leading companies in Switzerland. Stocks are selected based on rankings by float-adjusted market capitalization and average trading volume. The Index is weighted in accordance with free-float market capitalisation principles, with an upper weighting limit of 10% in relation to each share. More information about the composition of the Index and its operating rules are available in the prospectus and at: www. eu.spindices.com The Index value is available via Bloomberg (DJCH30TR). The exposure to the Index will be achieved through a direct replication, mainly by making direct investments in transferable securities and/or other eligible assets representing the Index constituents in a proportion extremely close to their proportion in the Index. The exposure to the Index will be achieved through a Direct Replication, mainly by making direct investments in transferable securities and/or other eligible assets representing the Index constituents in a proportion extremely close to their proportion in the index. The Investment Manager will be able to use derivatives in order to deal with inflows and outflows and also if it allows a better exposition to an Index constituent. In order to generate additional income to offset its costs, the Sub-Fund may also enter into securities lending operations. The Sub-Fund's shares are listed and traded on one or more stock exchanges. In normal circumstances, you may deal in

Physical replication

PIR compliant

No

PEA compliant

No

PEA-PME compliant

No